Test of blood plasma as COVID-19 weapon gets a slow start
April 21, 2020 at 08:09 AM EDT
Mayo Clinic is leading a nationwide trial of blood plasma from recovered patients of COVID-19, with the goal of using it to help treat or prevent new cases, but the launch has been delayed by — among other things — a shortage of recovered patients.
